Form 13-F position report

IONIS PHARMACEUTICALS INC

Reported by WOLVERINE ASSET MANAGEMENT LLC

IONS 0 04/01/26 CUSIP 462222AD2 Manager CIK 0001279891

First reported at 0 shares this quarter.

Unchanged
% of reported 13F value 0.98% This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $98,202,000 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-06-30 98202000
2022-09-30 106622000
2022-12-31 101603446
2023-03-31 93805550
2023-06-30 86009766
2023-09-30 40173472
2023-12-31 23651352
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for IONIS PHARMACEUTICALS INC held by WOLVERINE ASSET MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Unchanged 0 0 (0.0%) 0 $0 2024-05-13
Q4 2023 Unchanged 0 0 (0.0%) 0.2% $23,651,352 2024-02-01
Q3 2023 Unchanged 0 0 (0.0%) 0.45% $40,173,472 2023-11-13
Q2 2023 Unchanged 0 0 (0.0%) 1.02% $86,009,766 2023-08-07
Q1 2023 Unchanged 0 0 (0.0%) 1.11% $93,805,550 2023-05-08
Q4 2022 Unchanged 0 0 (0.0%) 1.05% $101,603,446 2023-02-01
Q3 2022 Unchanged 0 0 (0.0%) 1.15% $106,622,000 2022-11-10
Q2 2022 Unchanged 0 0 (0.0%) 0.98% $98,202,000 2022-08-03

Who else reported the position

35 managers reported IONIS PHARMACEUTICALS INC for Q2 2022.

Managers reporting IONIS PHARMACEUTICALS INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
DEERFIELD MANAGEMENT COMPANY L P SERIES C New 127,800,000 +127,800,000 2.41% $116,991,000 1 qtr
WOLVERINE ASSET MANAGEMENT LLC This report Unchanged 0 0 0.98% $98,202,000 1 qtr
TENOR CAPITAL MANAGEMENT Co L P New 55,000,000 +55,000,000 1.14% $50,484,000 1 qtr
ADVENT CAPITAL MANAGEMENT DE New 25,000,000 +25,000,000 0.4% $22,858,000 1 qtr
BlackRock Inc New 22,425,000 +22,425,000 < 0.01% $20,391,000 1 qtr
MACKAY SHIELDS LLC New 20,373,000 +20,373,000 0.45% $18,627,000 1 qtr
WHITEBOX ADVISORS LLC New 17,855,000 +17,855,000 0.5% $16,236,000 1 qtr
Magnetar Financial LLC Unchanged 0 0 0.16% $15,322,000 1 qtr
CAPSTONE INVESTMENT ADVISORS LLC New 16,200,000 +16,200,000 0.07% $14,812,000 1 qtr
AMERIPRISE FINANCIAL INC New 15,908,000 +15,908,000 < 0.01% $14,465,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 03, 2022
Filing type
13F-HR
Position type
NOTE 4/0

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.